Opinions Plus

Perspectives on issues affecting biopharma and health care.

D.C. Insight IMAGE

Opinions Plus

Tell us what you really think: A survey on drug prices, biotech, and Alex Azar

By Elizabeth Cooney

C-Suite illustration

Opinions Plus

From the C-suite: Biopharma execs teach students a lesson

By STAT staff

C-Suite illustration

Opinions Plus

From the C-Suite: nurturing diversity in the workplace

By STAT staff

Happy 2018

Opinions Plus

Industry insiders are upbeat about 2018, but that doesn’t mean more hiring

By Elizabeth Cooney

C-Suite illustration

Opinions Plus

From the C-Suite: advice on dealing with antsy investors

By STAT staff

C-Suite illustration

Opinions Plus

From the C-Suite: How to coach a team to respond to setbacks

By STAT staff

C-Suite illustration

Opinions Plus

From the C-Suite: How to learn leadership skills from mentors as diverse as Gen. Patton — and mom

By STAT staff

C-Suite illustration

Opinions Plus

From the C-Suite: How to build a strong workplace culture

By STAT staff

C-Suite illustration

Opinions Plus

From the C-Suite: Biopharma execs open up on what tests them as leaders

By STAT staff

C-Suite illustration

Opinions Plus

From the C-Suite: Biotech execs share their best interview questions — and the answers they want to hear

By STAT staff

Opioid Tablets

Opinions Plus

Doctors, beware: Prosecutors are zooming in on health care fraud as opioid crisis mounts

By Robert M. Thomas Jr.